Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

8-K - Current report

Form Type: 8-K

Filing Date: 2019-03-12

View Filing

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2019-03-12

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2019-03-01

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2019-02-22

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2019-02-14

View Filing

PX14A6G - Notice of exempt solicitation submitted by non-management

Form Type: PX14A6G

Filing Date: 2019-02-14

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2019-02-13

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2019-02-07

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2019-01-23

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2019-01-14

View Filing